Working out of Copenhagen, with affiliates in San Francisco and Boston, Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

The Roche Venture Fund invests in early stage biotech, digital and diagnostics companies to develop commercially successful innovative life science companies. Based in Basel, Switzerland with an office in South San Francisco, the Roche Venture Fund invests globally with a portfolio of over 35 companies in 10 countries. For more information, please visit venturefund.roche.com.

Versant Ventures is a leading healthcare venture capital firm committed to helping exceptional entrepreneurs buildthe next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics.

Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and Greater China. With more than $3.0 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and Greater China. Vivo Capital has offices in Palo Alto, California, Beijing and Shanghai, China, and Taipei, Taiwan.